Amato RJ - Search Results

1

The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial.

Cohen L, de Moor C, Amato RJ. Cohen L, et al. Among authors: amato rj. Cancer. 2001 May 15;91(10):1949-55. doi: 10.1002/1097-0142(20010515)91:10<1949::aid-cncr1218>3.0.co;2-a. Cancer. 2001. PMID: 11346878 Clinical Trial.

2

A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma.

de Moor C, Sterner J, Hall M, Warneke C, Gilani Z, Amato R, Cohen L. de Moor C, et al. Health Psychol. 2002 Nov;21(6):615-9. doi: 10.1037//0278-6133.21.6.615. Health Psychol. 2002. PMID: 12433015 Clinical Trial.

3

Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine.

Cohen L, de Moor C, Parker PA, Amato RJ. Cohen L, et al. Among authors: amato rj. Urol Oncol. 2002 May-Jun;7(3):119-24. doi: 10.1016/s1078-1439(01)00182-x. Urol Oncol. 2002. PMID: 12474545 Clinical Trial.

4

Endocrine levels at the start of treatment are associated with subsequent psychological adjustment in cancer patients with metastatic disease.

Cohen L, de Moor C, Devine D, Baum A, Amato RJ. Cohen L, et al. Among authors: amato rj. Psychosom Med. 2001 Nov-Dec;63(6):951-8. doi: 10.1097/00006842-200111000-00014. Psychosom Med. 2001. PMID: 11719634

5

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma.

Pagliaro L, Daliani D, Amato R, Tu SM, Jones D, Smith T, Logothetis C, Millikan R. Pagliaro L, et al. Cancer. 2000 Aug 1;89(3):615-8. Cancer. 2000. PMID: 10931461 Clinical Trial.

6

Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.

Ellerhorst JA, Sella A, Amato RJ, Tu SM, Millikan RE, Finn LD, Banks M, Logothetis CJ. Ellerhorst JA, et al. Among authors: amato rj. Cancer. 1997 Dec 1;80(11):2128-32. Cancer. 1997. PMID: 9392335 Clinical Trial.

7

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.

Amato RJ, Jac J, Giessinger S, Saxena S, Willis JP. Amato RJ, et al. Cancer. 2009 Jun 1;115(11):2438-46. doi: 10.1002/cncr.24280. Cancer. 2009. PMID: 19306412 Free article. Clinical Trial.

8

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma.

Daliani DD, Papandreou CN, Thall PF, Wang X, Perez C, Oliva R, Pagliaro L, Amato R. Daliani DD, et al. Cancer. 2002 Aug 15;95(4):758-65. doi: 10.1002/cncr.10740. Cancer. 2002. PMID: 12209719 Free article. Clinical Trial.

9

Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma.

Amato RJ, Morgan M, Rawat A. Amato RJ, et al. Cancer. 2006 Apr 1;106(7):1498-506. doi: 10.1002/cncr.21737. Cancer. 2006. PMID: 16475152 Free article. Clinical Trial.

10

Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.

Che M, Tamboli P, Ro JY, Park DS, Ro JS, Amato RJ, Ayala AG. Che M, et al. Among authors: amato rj. Cancer. 2002 Sep 15;95(6):1228-33. doi: 10.1002/cncr.10804. Cancer. 2002. PMID: 12216089 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters